OPK (OPKO Health Inc) Gross Profit Rate

OPK (OPKO Health Corp.) - company brandmark

OPKO Health, Inc. (OPK) leverages the synergy between veterinary medicine and diagnostics, monetizing licensing payments for Ngenla. Robotics and AI optimize sample analysis, reducing manual labor. A strategic pivot involves divesting unprofitable assets in favor of biopharmaceuticals. The current status is 31.60, which is detailed in the target gross margin trend.

Gross Margin: OPKO Health, Inc. (OPK) for 07/04/2022 - 11/20/2026

Comprehensive metric breakdowns and analytics for OPKO Corp (OPK)

- business market valuation indicators:
Fundamental valuation:OPKO Corp (OPK)
Finished products of OPKO Health Inc

Long-term risk control requires monitoring operational efficiency, making changes in gross profit margin critical for assessing business sustainability. For OPKO Health, Inc. (OPK), this metric reflects the portion of revenue remaining after deducting direct costs for laboratory diagnostics and drug development, demonstrating how successfully the company optimizes research expenses and interactions with insurance providers.